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http://dx.doi.org/10.1016/j.jfma.201
0929-6646/Copyright ª 2015, ElsevierBackground/purpose: An influenza A pandemic occurred in 2009e2010. A novel H1N1 virus
(hereafter H1N1pdm) was responsible for this outbreak. H1N1pdm viruses have been largely
seen in recent human influenza A viruses. This virus was descended from a triple-reassorted
swine virus consisting of human, avian, and swine origins. As a result, the previously estab-
lished species-associated signatures could be in jeopardy.
Methods: We analyzed all influenza A sequences in the past 5 years after the inclusion of
H1N1pdm into human viruses since 2009, and examined how human signatures may lose their
distinctness by mixing with avian residues that H1N1pdm have brought in. In particular, we
compared how those signatures were changed/shifted in the past 5 years for human-isolated
avian influenza A viruses and discussed their implications.
Results: Only eight out of 47 signatures remained human-like for human influenza A viruses in
the past 5 years. They are PB2 271A; PB1 336I; PA 356R and 409N; NP 33I, 305K, and 357K; and
NS1 227R. Although most avian-like residues were preserved in human-isolated avian influenza
A viruses, a number of them were found to have become or on the verge of becoming human-
like, including PB2 627, PA 100, 356, 404, 409, NP 33, 61, 305, 357, M2 20, and NS1 81.
Conclusion: Analyzing how species-associated signatures are becoming human-like in human-
isolated avian influenza A viruses helps in assessing their potential to go pandemic as well as
providing insights into host adaptation.
Copyright ª 2015, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.have no conflicts of interest relevant to this article.
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Plasticity of influenza A genomic signatures 457IntroductionInfluenza A virus can infect various hosts including birds,
swine, and some mammals. A number of pandemics
occurred in humans, including the 1918 H1N1 (Spanish flu),
1957 H2N2 (Asian flu), and 1968 H3N2 (Hong Kong flu). Ca-
sualties were catastrophic in these global infections.
Recent endemics of highly pathogenic avian influenza A
viruses also caused human deaths. Such seemingly sporadic
and regional infections constantly raise concern that an
avian influenza A virus could mutate to become easily
transmissible between humans, raising the possibility for
another influenza pandemic. Notable examples include the
H5N1 virus since 2003, and the H7N9 virus since 2013.1e3
Other reported human cases of avian influenza A virus
also include H7N7 and H9N2.4,5
Recently, a single substitution from glutamic acid (E) to
lysine (K) at PB2 627 of avian influenza viruses was found to
enhance their replications in mammalian cells.6,7 Observing
that the distribution of PB2 K versus E was each dominant in
human and avian influenza A viruses, we developed an
entropy-based method that outlined a number of amino
acid positions, wherein each contains a distinct residue in
either avian or human viruses. Fifty-two signatures were
revealed based on large-scale sequence analysis of 306
human and 95 avian virus genomes in 2006.8 We further
revalidated them into 47 signatures in 2009 based on more
than 3000 genomes each for human and avian influenza A
viruses.9 These signatures provide not only markers of
diagnosing if a novel influenza A virus can be attributed to
either a human or avian virus, but also molecular targets for
scientists to probe host adaptability.10,11 Note that an
entropy-based algorithm heavily depends on a good multi-
ple sequence alignment. As a result, the two surface pro-
teins, HA and NA, have been excluded from the discussion,
specifically their species-specific signatures, because too
many gaps would have been introduced from aligning these
diverse sequences among subtypes.8
A novel influenza A H1N1 pandemic (hereafter
H1N1pdm) occurred in early 2009 and caused severe
morbidity and fatality.12,13 Not only was this the first human
pandemic in recent years, the new virus also featured
multiple genes from different origins, and some of these
genes were previously reassorted from their more distant
ancestors, including birds.14,15 For example, the two poly-
merase genes PB2 and PA were traced back to the avian
influenza A viruses of North American lineage in the late
1970s. They were cointroduced together with human-origin
genes of PB1, HA, and NA (from human H3N2 dated back to
as early as 1968) into a swine population in around the early
1990s. This virus population was named a triple-reassorted
swine influenza A virus, with its third origin consisting of
swine H1N1 genes of NP, M, and NS from the classical swine
virus of Eurasia and North America. It later acquired a new
HA and NA gene also from the classical swine virus in Eur-
asia and North America and was detected as a novel swine
reassortant in late 1990s. Avian HA and M genes from the
North American H1N1 avian virus then replaced the two
genes in this swine virus, and the resulting swine virus was
detected with sporadic human infections in the late 1990s
into early the 2000s. Finally, an outbreak of new humanH1N1commenced in 2009 based on this reassorted,
multiple-origin genome.
Regardless of the multiple origins of this new influenza A
virus, H1N1pdm has been considered a human virus since its
debut in 2009, primarily because of its extensive infection
and transmission capability in humans. After the 2009
outbreak, the H1N1pdm literally replaced the old H1N1
(previously known as the seasonal H1N1) viruses and
became a human seasonal influenza virus just like H3N2.
Viewing that many H1N1pdm virus genes were descended
from avian viruses (some directly, and some indirectly via
swine species), we wondered if some of the 47 human-
eavian genomic signatures that we established earlier
would be in jeopardy. In this study, we analyzed all influ-
enza A sequences in the past 5 years after the inclusion of
H1N1pdm into human viruses, and examined how human
signatures may lose their distinctness by mixing with avian
residues that H1N1pdm has brought in. In particular, we
compared how those signatures were changed/shifted in
the past 5 years for human-isolated avian influenza A vi-
ruses and discuss their implications.
Materials and methods
Influenza virus sequences
Influenza A virus sequences were downloaded from Influ-
enza Virus Resource as of April 2014.16 Only full-length
amino acid sequences were gathered, and identical se-
quences in each dataset were collapsed by keeping only the
oldest one in the group. All sequences were grouped into
two temporal phasesdPhase 1 of viruses isolated before
December 2008 and Phase 2 of viruses isolated in the most
recent five seasons from January 2009 to April 2014. In each
phase, we further divided the viruses into three categories:
avian-isolated avian viruses, human-isolated avian viruses,
and human-isolated human viruses.
Template-based multiple sequence alignments
Sequences were multiply aligned using an in-house-
developed algorithm called template-based multiple
sequence alignment (TMSA). It takes advantage of the fact
that the sequences to be aligned are genetically close, so
that no gaps (or very limited ones) are inserted. In short,
TMSA outlines a reference sequence called R; based on it,
every sequence to be aligned (Ti, where iZ 1,n) is compared
using a pairwise alignment program needle in the European
Molecular Biology Open Software Suite package.17 All
resulting pairwise alignments are then assembled into the
multiple sequence alignment (MSA) and curated for any
anomalies that are not compatible with the coordinate sys-
tems in documenting the 47 signature positions. The time
complexity is reduced from O(n2) to O(n) by using TMSA
rather than some traditional MSA tools such as ClustalW.18
Sequence logos for signature positions
We used WebLogo (version 3.4, http://weblogo.
threeplusone.com/) to graph the sequence logos of
458 G.-W. Chen et al.stacking amino acid symbols for each aligned position, with
the height of symbols indicating the relative frequency of
each amino acid.Results
Obscuring of signatures between avian and human
influenza A viruses
Sequence counts for different temporal or subtype group-
ings used in this study are summarized in Table 1. Recall
that only full-length sequences were downloaded, and
identical sequences were collapsed. As a result, these
counts represent the number of “genotypes” for a given
protein rather than the number of viruses. For example, the
collapsed PB2 sequence count prior to December 2008 was
1342 (31% of the originally collected 4324 sequences) for
human viruses and 3454 (53% of the original 6485 se-
quences) for avian viruses. The sequence count reduction
due to collapsing was in general more significant in human
viruses than in avian viruses because the latter comprised
more subtypes (hence more genetic diversity) than in
human viruses. Smaller proteins exhibited a more signifi-
cant reduction of sequence counts due to collapsing iden-
tical sequences, too. Taking the 97-aa M2 protein, for
example, the collapsed sequence count prior to December
2008 was 538 (only 11% of the original 4972 sequences) for
human viruses and 1091 (16% of original 6974 sequences) for
avian viruses.
We first produced the web logos for 47 signatures in
Fig. 1 from influenza A sequences we collected with their
isolation time dated before December 2008. Note that
human-isolated avian viruses (e.g., H5N1, H7N7, H9N2,
H7N9) were not included as human influenza A viruses.
Neither were they considered avian viruses in this figure.
These 47 signature positions are scattered in PB2, PB1, PA,
NP, M1, M2, NS1, and NS2 proteins. NP is the most abundant
with 15 signature positions, whereas NS2 contains the least
(only one). If one normalizes the signature counts per 100-
aa-long segment, it would be M2, NP, PA, PB2, and M1 that
contain the most abundantd5.15, 3.01, 1.40, 1.19, and
1.19 signatures, respectively. PB1 627 is the most
mentioned species-associated signature position. A human-
like residue K is clearly seen for human influenza A viruses,Table 1 Sequence counts used for investigating signature diver
Group/Gene PB2 PB1 PA
Hu-Hu (Dec 2008) 1342 1324 1265
Av-Av (Dec 2008) 3454 3207 3721
Hu-Hu (Jan 2009) 1528 1373 1483
Av-Av (Jan 2009) 1430 1286 1440
Hu-H1N1(Jan 2009) 1203 1046 1136
Hu-H3N2(Jan 2009) 325 327 347
Hu-Av (Dec 2008) 149 116 140
Hu-Av (Jan 2009) 42 28 34
Av-Av Z avian-isolated avian viruses; Hu-Av Z human-isolated avian
human viruses (including H1N1, H1N2, H2N1, and H3N2); Hu-H1N1 Z
viruses.whereas an E (with a very small population showing K at the
bottom of the logo) is characteristic in avian viruses.
Fig. 2 shows the web logos of humaneavian signatures
for all influenza A sequences dated after January 2009.
Whereas the avian logos remain mostly the same between
Figs. 1 and 2, the ones for humans are very different in
terms of amino acid compositions. In particular, most of
them appear to be divided, with the dominant residues
avian-like rather than human-like. Taking the famous PB2
627, for example, the new human viruses are mostly
showing an avian-like E over the human-like K. Fig. 2 il-
lustrates how the inherited avian-origin residues in the
H1N1pdm viruses may “invade” and alter the dominant
residues. This observed residue compositions were also a
direct result of the sampling of human virus sequences after
2009, in which H1N1pdm virus count dominated over the
seasonal H3N2 by a ratio of approximately 2e4:1 (see Table
1). Interestingly, a number of signatures remained human-
like (labeled with red dots in Fig. 2), including PB2 271A,
PB1 336I, PA 356R and 409N (a small portion with avian-like
S), NP 33I, 305K and 357K, and NS1 227R. In other words,
the seemingly divided human H1N1pdm and H3N2 pop-
ulations agreed upon the same human-like amino acid
residues only at these eight locations.
To better examine the signatures within each of the two
major human influenza A viruses after 2009, we produced
their subtype-specific signatures in Fig. 3 for comparison. It
is clearly shown that human seasonal H3N2 viruses after
2009 followed the earlier predicted human signatures very
well, except that PB2 613 that was once dominated by a
human-like T in Fig. 1 is now mostly a neutral A (not the
avian-like V), and PA 409 that was once a human-like N is
now dominated by an avian-like S. Both PB2 613 and PA 409
logos of H3N2 viruses are dotted with green rectangles in
Fig. 3, together with some other noticeable H3N2 mutations
including NP 100V containing some neutral I (not avian-like
R), and M2 11I containing some avian-like T. These repre-
sent positions having their residues turned into or were on
the verge of becoming nonhuman-like. We additionally
labeled PA 409 and M2 11 by green dots for these H3N2 vi-
ruses, emphasizing their potential for gaining more avian-
like residues after 2009. By contrast, H1N1pdm after 2009
exhibited mostly avian-like residues, except for PB2 271A,
PB1 336I, PA 356R and 409N, NP 33I, and 305K and 357K (all
with red dots) that we already observed in Fig. 1. Note thatsity.
NP M1 M2 NS1 NS2
880 375 538 1198 348
2207 1042 1091 3032 1166
657 390 396 1043 316
879 318 496 1084 473
499 284 238 753 231
158 106 158 290 85
94 40 56 119 65
30 13 17 46 23
viruses (including H5N1, H7N7, H7N9); Hu-Hu Z human-isolated
human-isolated H1N1 viruses; Hu-H3N2 Z human-isolated H3N2
Figure 1 Web logos displaying the amino acid residue compositions for 47 species-associated amino acid signatures in Phase 1
(before the new H1N1 viruses were introduced in 2009). Human-like residues are displayed at the top row, and avian-like residues
at the bottom row. These 47 positions are PB2 44, 199, 271, 475, 567, 588, 613, 627, 702 (total of 9 positions); PB1 327, 336 (2
positions); PA 28, 55, 57, 100, 225, 268, 356, 404, 409, 552 (10 positions); NP 16, 33, 61, 100, 109, 214, 283, 293, 305, 313, 357, 372,
422, 442, 455 (15 positions); M1 115, 121, 137 (3 positions);M2 11, 20, 57, 86, 93 (5 positions); NS1 81, 227 (2 positions); and NS2 107
(1 position). All positions shown in each logo are from left to right.
Plasticity of influenza A genomic signatures 459H1N1pdm viruses featured a truncated NS1 of 219 aa long.
As a result, they did not contribute to the web logo for NS1
227 in Fig. 3. Lastly, we point out a number of signature
positions on which the H1N1pdm viruses have mutated into
neither human- nor avian-like residues. These are PB2 588
dominated by T (with a minor human-like I), NP 100 by I
(with a minor human-like V), and NP 313 by V (with a minor
human-like Y). These, together with NS1 227 of a deletion
in H1N1pdm viruses, are dotted with red rectangles in
Fig. 3.
It is known that the H1N1pdm virus descended from the
triple reassorted swine influenza A viruses in the late 1990s
to the early 2000s. These triple reassortants inherited their
genes from three distinct originsdPB2 and PA from the
avian viruses in the 1970s, PB1 from human H3N2 of 1968,
and NP from the classical swine viruses. Swine is known as a
mixing vessel of human and avian influenza A viruses. We
summarized the amino acid compositions of 15 NP signature
positions in Table 2, in which we clearly see the mixing of
residues in classical swine viruses. Note that the swine vi-
ruses were based on the dataset we analyzed in previous
work.9 Also included are the 18 triple reassortants of swineviruses that were considered the most ancestral strains of
H1N1pdm viruses, as well as 499 H1N1pdm viruses used in
this study.9 For each of these positions, the dominant res-
idues in classical swine seemed to be maintained in triple
reassortants as well as in H1N1pdm viruses, except for NP
100 and 313, wherein the former had a dominant V in
classical swine and triple reassortants but turned into an I
in H1N1pdm viruses, and the latter had an F in classical
swine and triple reassortants but a V in H1N1pdm viruses.
All these dominated residues were avian-like, except 33I,
305K, and 357K (which are human-like) and 100I (which is
neither a human-like V nor an avian-like R).More human-like residues in human-isolated avian
influenza A viruses
We compared how the signatures changed for human-
isolated avian viruses before and after 2009 in Fig. 4.
Human-isolated avian viruses are still avian viruses. They
maintained the same signatures as in avian viruses. This is
one reason that they have yet turned into “human” viruses.
Figure 2 Web logos for species-associated amino acid signatures in Phase 2 (after the H1N1pdm viruses were introduced in 2009).
Residues from human viruses (including H1N1pdm and seasonal H3N2 viruses) are displayed at the top row, and residues from avian
viruses at the bottom row. Eight positions are labeled with red dots for their maintaining human-like residues as the human viruses
were joined by H1N1pdm viruses.
460 G.-W. Chen et al.Still, some shifting of amino acid compositions can help
reveal how these viruses may change their genomic outfits
to suggest better or less transmission in humans. For viruses
collected before 2008, for example, PB2 positions 44, 199,
613, and 702 all contained a small portion of human-like
residues (S, S, T, and R, respectively). These human-
prone mutations turned barely visible in the logos for
human-isolated avian viruses after 2009. Similar fading-out
of human-like residues in recent human-isolated avian vi-
ruses also included PA 28L, 55N, 552S, and M1 137A. Green
dots are used in Fig. 4 to highlight those decaying human-
like residues. By contrast, whereas PB2 627 is already
seeing a good portion of it as human-like K, this proportion
seemed to become more significant in the recent five sea-
sons. Other signature positions with seemingly increased
appearance of human-like residues included PA 100A, 356R,
409N, NP 33I, 61L, 305K, 357K, and M2 20N. Note that a
human-like PA 404S and NS1 81M had already emerged prior
to 2008. Although their frequencies slightly fell after 2009,
they still displayed a visible logo of approximately 15e30%
in recent years. All these are labeled with red dots in Fig. 4
for striking their potential in crossing the avianehuman
species boundary.Discussion
The PB2, PB1, PA, NP, and NS genes of the new H1N1 viruses
were directly from the triple-reassorted swine viruses
circulating in the early 1990s, among which PB2 and PA
were further traced to H1N1 avian viruses, PB1 to human
seasonal H3N2, and NP and NS to classical swine H1N1 vi-
ruses.15 As a result, it is expected that those avian-origin
genes, PB2 and PA, would carry avian signatures into and
dominate in H1N1pdm. This was in general the case, as seen
in Fig. 3, except that PB2 271, PA 356, and PA 409 were
found carrying a human-like A, R, and N, rather than an
avian-like T, K, and S, respectively. How these three
signature positions stayed human-like remains an inter-
esting question to address.
Previously, we had collected 18 recent ancestral swine
viruses prior to H1N1pdm and inspected their amino acid
compositions.9 Although they were still swine viruses, we
found that their PB2 271 and PA 409 are dominated by
human-like residues A and N, respectively. This implies that
PB2 271 and PA 409 were already transformed from avian
into human signatures when the avian PB2 and PA segments
were introduced into the triple reassortants in swine
Figure 3 Web logos of species-associated amino acid signatures for human influenza A viruses in Phase 2. Residues from H1N1pdm
viruses are displayed at the top row, and residues from seasonal H3N2 viruses at the bottom row. Red dotted rectangles are used in
H1N1pdm viruses to show that the dominant residues were neither human- nor avian-like. Green dotted rectangles are used in
seasonal H3N2 viruses to show that the dominant residues have already turned or were on the verge of becoming nonhuman-like.
Green dots are used to label H3N2 positions displaying or having the potential to display avian-like signatures.
Table 2 Amino acid compositions of 15 signature positions for influenza A NP gene.
Position Classical swinea Triple reassortantsa H1N1pdmb Human signatures Avian signatures
16 G(350), D(45) G(18) G(457), D(39) D G
33 I(271), V(130) I(18) I(497) I V
61 I(355), L(43) I(17), M(1) I(459), L(34) L I
100 V(192), R(127), I(85) V(17), I(1) I(380), V(111) V R
109 I(353), V(41) I(18) I(458), V(38) V I
214 R(330), K(54) R(17), K(1) R(464), K(34) K R
283 L(371), P(44) L(18) L(463), P(35) P L
293 R(372), K(43) R(18) R(465), K(34) K R
305 K(280), R(135) K(18) K(493) K R
313 F(366), Y(44) F(18) V(458), Y(34) Y F
357 K(268), Q(127) K(17), R(1) K(493) K Q
372 E(377), D(42) E(18) E(464), D(34) D E
422 R(349), K(47) R(17), K(1) R(464), A(35) K R
442 T(356), A(40) T(18) T(466), A(33) A T
455 D(354), E(41) D(18) D(464), E(35) E D
a Based on data used by G.-W. Chen and S.-R. Shih, “Genomic signatures of influenza A pandemic (H1N1) 2009 virus,” 2009, Emerging
Infect Dis, 15, p. 1897e903. Copyright 2009, Emerging Infectious Diseases. With permission.
b Based on 499 collapsed NP sequences of H1N1pdm viruses collected in this study. The most dominant amino acids in each of the 3 virus
populations (first 3 columns) are bold-and-underlined for clarity. Signature residues matching the two swine viruses (first 2 columns) are
also bold-and-underlined in the last 2 columns, suggesting the residues observed in the swine viruses are either human- or avian-origin.
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Figure 4 Web logos of species-associated amino acid signatures for human-isolated avian influenza A viruses. Residues from
viruses isolated before December 2008 (Phase 1) are displayed in the top row, and ones after January 2009 (Phase 2) in the bottom
row. Green dots are used to label positions of diminishing human-like residues. Red dots are used for positions of already showing or
on the verge of increasing the exposure of human-like residues.
462 G.-W. Chen et al.populations in around the early 1990s or at even some
earlier time. Oppositely, PA 356 in recent ancestral swine
viruses was still an avian-like K. A switch from K to human-
like R in the H1N1pdm might suggest its role in species
adaptation.
By contrast, PB1 of H1N1pdm was traced to human H3N2
in 1968. It would thus be natural that PB1 signatures will
stay human-like. In fact, PB1 336 maintained a human-like I
as expected. The other PB1 signature at position 327,
however, was dominated by an avian-like R for H1N1pdm in
Fig. 3. PB1 327 already carried an R in the recent triple
reassortant swine viruses (data not shown). This implies the
transitioning from the human-like K to the avian-like R in
the triple reassortants, and the subsequent H1N1pdm must
have occurred prior to the detected triple reassortants in
the early 1990s. More sequences sampled between early
1970s to late 1980s may provide better pictures of such
transitions.
Althoughmost of theNP signaturepositions shown inTable
2 were dominated by avian residues in classical swine pop-
ulations, four were marginally displaying human-like resi-
dues, including NP 33, 100, 305, and 357. In particular, NP 33,
305, and 357 seemed to consistently display an approxi-
mately 2:1 ratio of human- versus avian-like residues.Surprisingly, these three NP signature positions had their
residues “purified” to contain only human-like residues in
triple reassortants as well as in H1N1pdm viruses. This is why
they appeared as human signatures for human influenza A
viruses after the year 2009 shown in Figs. 2 and 3. By contrast,
NP 100 comprised a third residue I that was neither human-
nor avian-like, in addition to a human-like Vand an avian-like
R in the classical swine viruses. The avian-like R was
completely eliminated in H1N1pdm; instead the residue I
became dominant followed by a human-like V. These statis-
tics seemed to suggest some distinct roles that NP 33, 100,
305, and 357 may have played in shaping a swine virus to
better fit in humans.
The H1N1pdm viruses have joined the human influenza A
virus population for only 5 years. Because they inherited
the genomic features from the triple reassortants, they
contain amino acids that are characteristic in avian,
human, and swine viruses. This effectively makes the
human virus population much more diverse after 2009, with
the addition of the H1N1pdm viruses. Even though we have
eliminated the sequence redundancies by collapsing them
prior to evaluating their diversities, the bulky H1N1pdm
sequences still dictated the human virus population such
that the entropy-based method in revealing humaneavian
Plasticity of influenza A genomic signatures 463signatures ended up with only eight such positions, rather
than the previously found 47 prior to 2009. This, however,
does not mean that the established 47 species-associated
signatures are not useful. Prior to H1N1pdm, the human
viruses had been “shaped” by human host factors for > 40
years since the last H3N2 pandemic in 1968. As a result,
these 47 signatures are eligible to suitably mark a genetic
boundary between human and avian influenza A viruses. It
will be interesting to see how this boundary evolves in many
years to come. We did not follow other amino acid positions
that did not contribute to the genetic boundary between
the two species. Before December 2008, they either had
common residues between avian and human viruses, or the
position-specific amino acids were diverse enough such that
no distinct consensus residue can be called to mark the
species boundary we intended to reveal. After the massive
influx of H1N1pdm in 2009, we would expect a more varied
genetic landscape in those nonsignature positions than
before. Such diversity, however, was introduced because of
gene reassortment rather than host factors shaping those
47 signature positions on a long-term basis. As a result, we
did not investigate the distribution of similarity level for all
other positions.
This study pooled all human-isolated avian viruses
together in producing Fig. 4. This helps in assessing the
potential for an avian virus to overcome the avianehuman
species barrier, as well as identifying amino acid positions
that may play some roles in host adaptation. The summa-
rized information is in general applicable for all subtypes
including H5N1, H7N7, and H9N2. One could do the same
analysis using only human-isolated avian viruses of one
specific subtype, for example, the recent H7N9 viruses. This
may provide different observations and insights into host
adaptation.
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